Alprazolam Tablet
NDC Package 42816-0029-9

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Alprazolam tablets is alprazolam is used to treat anxiety and panic disorders. This formulation utilizes a tablet delivery system. Marketed by Pfizer Ireland Pharmaceuticals Unlimited Company, this product is identified by NDC 42816-0029.

Identification & Billing

NDC Package Code
42816-0029-9
Package Description
1 BAG in 1 DRUM / 85767 TABLET in 1 BAG
Product Code
11-Digit Billing Format
42816002909

Clinical Specifications

Proprietary Name
Alprazolam
Non-Proprietary Name
Alprazolam
Substance Name
Alprazolam
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Active Ingredient(s)
Usage Information
Alprazolam is used to treat anxiety and panic disorders. It belongs to a class of medications called benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. It works by enhancing the effects of a certain natural chemical in the body (GABA).
DEA Schedule
Schedule IV (CIV) Substances

Regulatory & Marketing

Labeler Name
Pfizer Ireland Pharmaceuticals Unlimited Company
Product Type
Drug For Further Processing
Marketing Category
DRUG FOR FURTHER PROCESSING - A drug (other than the bulk ingredient API) that is in an interim stage of manufacture, processing, preparation, or packaging, and not ready for human or animal use.
Start Marketing Date
10-16-1981
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 42816-0029-9 identifies a specific commercial package of 1 bag in 1 drum / 85767 tablet in 1 bag of Alprazolam (UNFINISHED drug), drug for further processing labeled by Pfizer Ireland Pharmaceuticals Unlimited Company. This tablet is formulated for use and contains alprazolam as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pfizer Ireland Pharmaceuticals Unlimited Company on October 16, 1981. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Alprazolam is used to treat anxiety and panic disorders. It belongs to a class of medications called benzodiazepines which act on the brain and nerves (central nervous system) to produce a calming effect. It works by enhancing the effects of a certain natural chemical in the body (GABA).

How is this Pfizer Ireland Pharmaceuticals Unlimited Company product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 42816002909. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
42816-0029-9
11-Digit CMS (5-4-2)
42816-0029-09

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.